| Literature DB >> 26777931 |
Stany Sandrio1, Ariawan Purbojo2, Robert A Cesnjevar2, André Rüffer2.
Abstract
As survival among patients with complex congenital heart disease continues to improve, long-term survivors frequently require redo surgical procedures, with potentially escalating technical difficulty and bleeding risk. This report describes our experience with a new hemostatic pad, Hemopatch (Baxter Deutschland GmbH, Unterschleissheim, Germany) in redo cardiac surgery.Entities:
Mesh：
Substances：
Year: 2016 PMID： 26777931 DOI： 10.1016/j.athoracsur.2015.04.082
Source DB: PubMed Journal: Ann Thorac Surg ISSN： 0003-4975 Impact factor: 4.330